News


201825JUN

Accelerating the delivery of new drugs to patients

A project aimed at accelerating the delivery of new drugs to patients, led by the University of Strathclyde and Glasgow School of Art, has received a grant of £1.9 million.
The funding has been awarded to ARTICULAR, a project which will use advances in digital technology to help reduce the time it takes to get new drugs to market by harnessing the potential of large data sets and Machine Learning more>>

201815JUN

Strathclyde in Medicines Manufacturing Innovation Centre

The University of Strathclyde is a strategic partner in a new £56 million UK innovation centre, which will revolutionise the way medicines are manufactured. The world-first, industry-led Medicines Manufacturing Innovation Centre (MMIC) will offer pharma companies, from start-ups through to multinational organisations, a service to develop and adopt novel manufacturing techniques to adapt into their own manufacturing processes. The centre is to be located in Renfrewshire. The MMIC will also translate to industry the output of the EPSRC Centre for Continuous Manufacturing and Advanced Crystallisation.
Full press release here.



201809MAY

Chemical Engineer Article May 2018

"Continuous crystallisation workflow enables high precision manufacturing of pharmaceuticals" Article by Amanda Doyle link here.

201826MAR

Chemistry World Article March 2018

"Solving the Crystal Maze" by Laura Fisher link here (subscribers only).

201821FEB

Enabling precision manufacturing of active pharmaceutical ingredients: workflow for seeded cooling continuous crystallisations

EPSRC CMAC CIM Workflow paper has gone online here: http://pubs.rsc.org/en/content/articlelanding/2018/me/c7me00096k#!divAbstract.
Congratulations to the team!


201719DEC

CMAC Welcomes Pfizer as Newest Partner

CMAC announces that Pfizer Inc has joined as a strategic member, alongside GSK, AZ, Novartis, Bayer, Takeda, Lilly and Roche.

Professor Alastair Florence of Strathclyde, Director of the CMAC EPSRC Research Future Manufacturing Research Hub, said: “Pfizer’s interests in continuous manufacturing are aligned with our Hub program, especially our common goal of improving development efficiency and manufacturing through digital design.”

“We are delighted to join CMAC and look forward to working together with other members to advance the pharmaceutical manufacturing process,” said Nick Thomson, Senior Director Technology API at Pfizer.

Further information can be found here.

News

Accelerating the delivery of new drugs to patients
A project aimed at accelerating the delivery of new drugs to patients, led by the University of Strathclyde and Glasgow School of Art, has received a grant of 1.9 million..... more

Strathclyde in Medicines Manufacturing Innovation Centre
The University of Strathclyde is a strategic partner in a new 56 million UK innovation centre, which will revolutionise the way medicines are manufactured..... more